PrxII deletion in mice with inactivating mutation of adenomatous polyposis coli (APC) gene reduces intestinal adenomatous polyposis via Axin/β-catenin axis and thereby promotes survival. This evidence concerns the gene PRDX2 and familial adenomatous polyposis 1.